锦欣生殖（01951）今日盘中表现强劲，股价大涨6.75%，引起市场广泛关注。截至发稿时，该股报价3.22港元，成交额达1.35亿港元。
股价上涨主要受益于美银证券发布的最新研报。该券商将锦欣生殖的目标价从3港元上调至3.5港元，同时维持"买入"评级。这一积极的分析观点显著提振了投资者信心，推动股价上扬。
值得注意的是，美银证券在研报中对锦欣生殖的财务表现进行了分析。公司去年预订收入同比小幅增长0.8%至28.12亿元人民币，但总利润同比下降6.5%至10.99亿元人民币，毛利率为39.1%。非国际财务报告准则调整后利润同比下降11.7%至4.16亿元人民币。尽管如此，美银证券仍看好公司前景，但将今明两年及2027财年的收入预测均下调12%。这表明尽管短期内可能面临挑战，但分析师对公司的长期发展依然持乐观态度。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.